Why Did Stanley Druckenmiller Buy ARS Pharmaceuticals?
Billionaire Stanley Druckenmiller has been making large changes to his…
Sell
30
SMLR Quote, Financials, Valuation and Earnings
Last price:
$51.92
Seasonality move
:
-12.74%
Day range:
$50.21 - $53.24
52-week range:
$20.88 - $81.56
Dividend yield:
0%
P/E ratio:
25.42x
P/S ratio:
6.88x
P/B ratio:
4.44x
Volume:
248.3K
Avg. volume:
566.2K
1-year change:
17.32%
Market cap:
$378.9M
Revenue:
$68.2M
EPS (TTM):
$2.05
Analysts' Opinion
-
Consensus RatingSemler Scientific has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $71.00, Semler Scientific has an estimated upside of 36.15% from its current price of $51.96.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $71.00 representing 100% downside risk from its current price of $51.96.
Fair Value
-
According to the consensus of 1 analyst, Semler Scientific has 36.15% upside to fair value with a price target of $71.00 per share.
SMLR vs. S&P 500
-
Over the past 5 trading days, Semler Scientific has underperformed the S&P 500 by -14.3% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Semler Scientific does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Semler Scientific revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Semler Scientific reported revenues of $13.5M.
Earnings Growth
-
Semler Scientific has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Semler Scientific reported earnings per share of $0.72.
Enterprise value:
366.3M
EV / Invested capital:
--
Price / LTM sales:
6.88x
EV / EBIT:
18.27x
EV / Revenue:
6.21x
PEG ratio (5yr expected):
0.24x
EV / Free cash flow:
-7.83x
Price / Operating cash flow:
7.89x
Enterprise value / EBITDA:
17.70x
Gross Profit (TTM):
$51.9M
Return On Assets:
19.02%
Net Income Margin (TTM):
27%
Return On Equity:
20.71%
Return On Invested Capital:
20.71%
Operating Margin:
37.49%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $54.4M | $66.9M | $58.9M | $16.3M | $13.5M | |
| Gross Profit | $49.2M | $62.1M | $51.9M | $15.2M | $12.4M | |
| Operating Income | $15.3M | $24M | $20M | $6.9M | $5.1M | |
| EBITDA | $15.9M | $24.5M | $20.7M | $7.1M | $5.2M | |
| Diluted EPS | $1.57 | $2.50 | $2.05 | $0.71 | $0.72 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $21.8M | $46.1M | $51.7M | $64.4M | $21.5M | |
| Total Assets | $28M | $51M | $60.9M | $79.4M | $92.2M | |
| Current Liabilities | $5.7M | $6.7M | $8.4M | $8.6M | $6.8M | |
| Total Liabilities | $6M | $7M | $8.6M | $8.7M | $6.8M | |
| Total Equity | $22.1M | $44M | $52.4M | $70.8M | $85.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $17.4M | $18.6M | $21.4M | $4.8M | $6.4M | |
| Cash From Investing | -$2.8M | -$24.5M | -$50.4M | -$6.8M | -$8.4M | |
| Cash From Financing | -$5.1M | -$2.1M | -$1.9M | -$51K | $1.2M | |
| Free Cash Flow | $15.8M | $16.7M | -$46.8M | $4.7M | -$2M | |
SMLR
Sector
Market Cap
$378.9M
$45.1M
Price % of 52-Week High
63.94%
48.02%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.75%
1-Year Price Total Return
16.1%
-32.06%
Beta (5-Year)
1.183
0.745
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$54.71
200-day SMA
Buy
Level
$37.01
Bollinger Bands (100)
Buy
Level
27.56 - 61.24
Chaikin Money Flow
Sell
Level
-8.9M
20-day SMA
Sell
Level
$55.93
Relative Strength Index (RSI14)
Sell
Level
43.08
ADX Line
Sell
Level
22.82
Williams %R
Neutral
Level
-66.8374
50-day SMA
Sell
Level
$59.62
MACD (12, 26)
Sell
Level
-1.59
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
7.3M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (33.0167)
Buy
CA Score
(Annual)
Level (3.2502)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-9.9673)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
Stock Forecast FAQ
In the current month, SMLR has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SMLR average analyst price target in the past 3 months is $71.00.
-
Where Will Semler Scientific Stock Be In 1 Year?
According to analysts, the consensus estimate is that Semler Scientific share price will rise to $71.00 per share over the next 12 months.
-
What Do Analysts Say About Semler Scientific?
Analysts are divided on their view about Semler Scientific share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Semler Scientific is a Sell and believe this share price will drop from its current level to $71.00.
-
What Is Semler Scientific's Price Target?
The price target for Semler Scientific over the next 1-year time period is forecast to be $71.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SMLR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Semler Scientific is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of SMLR?
You can purchase shares of Semler Scientific via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Semler Scientific shares.
-
What Is The Semler Scientific Share Price Today?
Semler Scientific was last trading at $51.92 per share. This represents the most recent stock quote for Semler Scientific. Yesterday, Semler Scientific closed at $51.96 per share.
-
How To Buy Semler Scientific Stock Online?
In order to purchase Semler Scientific stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CVS Health Stock Undervalued?
CVS Health (NYSE:CVS) share price declined by over 23% over…
How High Can RTX Stock Go?
Needless to say, the geopolitical landscape has heated up significantly…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 39x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Sell
38
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 101x
Alerts
Buy
54
DECK alert for Feb 1
Deckers Outdoor [DECK] is down 20.35% over the past day.
Sell
49
EXOD alert for Feb 1
Exodus Movement [EXOD] is down 18.88% over the past day.
Buy
69
HZO alert for Feb 1
MarineMax [HZO] is down 0.13% over the past day.
